Effect of Fexofenadine on Dog's Heart Performance
Neshat Mehrdad, Nabizadeh Behrouz, Safarmashaei Saeid
Abstract
Neshat Mehrdad, Nabizadeh Behrouz, Safarmashaei Saeid
Abstract
3 Abstract: Antihistamines are H blocker which is used in human and veterinary medicine. In humans for 1 treatment of allergic signs such as pruritus and anaphylactic reactions. The aim of this study was to evaluate fexofenadine effect on dog's heart performance. In this study 12 dogs were selected and Divided randomly into two groups, control and fexofenadine groups. Fexofenadine was given at two dose levels (3 and 18 mg/kg b.wt.) fexofenadine at the dose of the 3 and 18 mg/kgBW were administrated. In this study, the results revealed that fexofenadine has dose-independent effect on heart performance. It can be concluded that that administration of H -blockers as anti-histamincs in patients with cardiovascular disorders must be limited and prevented of 1 long-term usage in the patients in this patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
3 Abstract: Antihistamines are H blocker which is used in human and veterinary medicine. In humans for 1 treatment of allergic signs such as pruritus and anaphylactic reactions. The aim of this study was to evaluate fexofenadine effect on dog's heart performance. In this study 12 dogs were selected and Divided randomly into two groups, control and fexofenadine groups. Fexofenadine was given at two dose levels (3 and 18 mg/kg b.wt.) fexofenadine at the dose of the 3 and 18 mg/kgBW were administrated. In this study, the results revealed that fexofenadine has dose-independent effect on heart performance. It can be concluded that that administration of H -blockers as anti-histamincs in patients with cardiovascular disorders must be limited and prevented of 1 long-term usage in the patients in this patients.
Key concepts: Fexofenadine, Medicine, Terfenadine, Pharmacology